Zhen‐Ming Xu

491 total citations
25 papers, 388 citations indexed

About

Zhen‐Ming Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhen‐Ming Xu has authored 25 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Zhen‐Ming Xu's work include RNA modifications and cancer (9 papers), Cancer-related gene regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Zhen‐Ming Xu is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related gene regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Zhen‐Ming Xu collaborates with scholars based in China and United States. Zhen‐Ming Xu's co-authors include Wei‐Neng Fu, Kailai Sun, Yuanyuan Sun, Yunhui Li, Guang-Bin Qiu, Xiaowen Zhang, Shuang Fu, Ye Wang, Jin Wang and Hong Chen and has published in prestigious journals such as PLoS ONE, BioMed Research International and FEBS Journal.

In The Last Decade

Zhen‐Ming Xu

25 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhen‐Ming Xu China 13 321 187 54 39 27 25 388
Alexander E. Kudinov United States 5 235 0.7× 94 0.5× 70 1.3× 25 0.6× 34 1.3× 6 314
Kaori Yuuki Japan 7 330 1.0× 118 0.6× 68 1.3× 20 0.5× 49 1.8× 10 381
Mohammad Ahmad United States 11 237 0.7× 116 0.6× 141 2.6× 33 0.8× 35 1.3× 19 348
Mengna Zhan China 9 253 0.8× 201 1.1× 77 1.4× 21 0.5× 34 1.3× 13 367
Callie R. Merry United States 8 330 1.0× 252 1.3× 60 1.1× 18 0.5× 21 0.8× 8 383
H-Y Kang South Korea 5 211 0.7× 124 0.7× 50 0.9× 25 0.6× 11 0.4× 7 291
Haojie Dong China 10 220 0.7× 150 0.8× 26 0.5× 17 0.4× 23 0.9× 22 305
Qinghua Xi China 10 221 0.7× 77 0.4× 94 1.7× 38 1.0× 31 1.1× 17 289
Guiyuan Xie China 11 229 0.7× 91 0.5× 83 1.5× 40 1.0× 58 2.1× 18 335
Yao‐Jie Pan China 10 255 0.8× 190 1.0× 36 0.7× 17 0.4× 22 0.8× 17 319

Countries citing papers authored by Zhen‐Ming Xu

Since Specialization
Citations

This map shows the geographic impact of Zhen‐Ming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Ming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Ming Xu more than expected).

Fields of papers citing papers by Zhen‐Ming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen‐Ming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Ming Xu. The network helps show where Zhen‐Ming Xu may publish in the future.

Co-authorship network of co-authors of Zhen‐Ming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen‐Ming Xu. A scholar is included among the top collaborators of Zhen‐Ming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen‐Ming Xu. Zhen‐Ming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yuanyuan, et al.. (2020). MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway. Cellular Signalling. 74. 109709–109709. 21 indexed citations
2.
Sun, Yuanyuan, et al.. (2018). CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis. OncoTargets and Therapy. Volume 11. 1323–1331. 25 indexed citations
3.
4.
Wang, Ye, et al.. (2016). Methylation Status of SP1 Sites within miR-23a-27a-24-2 Promoter Region Influences Laryngeal Cancer Cell Proliferation and Apoptosis. BioMed Research International. 2016. 1–8. 12 indexed citations
5.
6.
Zhang, Xiaowen, Ning Liu, Sheng Chen, et al.. (2015). Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma. Oncology Letters. 10(1). 410–416. 19 indexed citations
7.
Tian, Yuan, Shuang Fu, Guang-Bin Qiu, et al.. (2014). MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2in laryngeal carcinoma. BMC Cancer. 14(1). 678–678. 58 indexed citations
8.
Liu, Jia, et al.. (2013). S100A4 is upregulated via the binding of c-Myb in methylation-free laryngeal cancer cells. Oncology Reports. 31(1). 442–449. 7 indexed citations
9.
Wang, Jin, et al.. (2011). The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma. Oral Oncology. 47(7). 601–608. 40 indexed citations
10.
Fu, Shuang, Yan Guo, Hong Chen, et al.. (2011). MYCT1-TV, A Novel MYCT1 Transcript, Is Regulated by c-Myc and May Participate in Laryngeal Carcinogenesis. PLoS ONE. 6(10). e25648–e25648. 21 indexed citations
11.
Chen, Hong, et al.. (2010). 14-3-3epsiloncontributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion. BMC Cancer. 10(1). 306–306. 35 indexed citations
12.
Fu, Wei‐Neng, et al.. (2008). S100A8 mediates the activation of P65/HLA-B/S100A8/BCL-2/Caspase-9 (−3) pathway in laryngeal carcinogenesis. Science Bulletin. 53(13). 2017–2024. 2 indexed citations
13.
Fu, Wei‐Neng, et al.. (2008). HLA-B gene participates in the NF-κB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2. Oncology Reports. 19(6). 1453–9. 8 indexed citations
14.
Li, Yinghui, et al.. (2005). STK15 Gene Overexpression, Centrosomal Amplification, and Chromosomal Instability in the Absence of STK15 Mutations in Laryngeal Carcinoma. Cancer Investigation. 23(8). 660–664. 11 indexed citations
15.
Li, Fucai, et al.. (2005). [Mutation of p53 and overexpression of STK15 in laryngeal squamous-cell carcinoma].. PubMed. 27(3). 134–7. 5 indexed citations
16.
Shang, Chao, et al.. (2004). [Comparative genomic hybridization analysis of laryngeal carcinoma].. PubMed. 31(6). 539–44. 2 indexed citations
17.
Li, Yinghui, et al.. (2004). [Association of homozygous deletion of p15 and p16 gene and amplification of EGFR gene in laryngeal squamous cell carcinoma].. PubMed. 31(2). 109–13. 3 indexed citations
18.
Li, Fucai, et al.. (2003). [Deletion of p15 and p16 genes and overexpression of STK15 gene in human laryngeal squamous cell carcinoma].. PubMed. 83(4). 316–9. 5 indexed citations
19.
Fu, Wei‐Neng, et al.. (2002). [Studies of the deletion and expression of cytokeratin 13 gene in laryngeal squamous cell carcinoma].. PubMed. 29(5). 390–5. 3 indexed citations
20.
Zhao, Zhen, et al.. (2002). [Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma].. PubMed. 19(2). 120–3. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander E. Kudinov Breakdown of academic impact, for papers by Kaori Yuuki Breakdown of academic impact, for papers by Mohammad Ahmad Breakdown of academic impact, for papers by Mengna Zhan Breakdown of academic impact, for papers by Callie R. Merry Breakdown of academic impact, for papers by H-Y Kang Breakdown of academic impact, for papers by Haojie Dong Breakdown of academic impact, for papers by Qinghua Xi Breakdown of academic impact, for papers by Guiyuan Xie Breakdown of academic impact, for papers by Yao‐Jie Pan
Rankless by CCL
2026